Anion exchanger 2 mediates the action of arsenic trioxide

British Journal of Haematology

Volumn 134, Issue 5, 2006, Pages 491-499

  Pan, Xiao Yan ^a,b   Chen, Guo Qiang ^a,b   Cai, Li ^c   Buscemi, Stephen ^d   Fu, Guo Hui ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

Anion exchange activity; Anion exchanger 2; Apoptosis; Arsenic trioxide; Differentiation

Indexed keywords

4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; ANION EXCHANGE PROTEIN 2; ANTIPORTER; ARSENIC TRIOXIDE; BICARBONATE; CARRIER PROTEIN; CD11B ANTIGEN; CHLORIDE ION; COMPLEMENTARY DNA; GLYCOPROTEIN P 15095; RETINOIC ACID RECEPTOR ALPHA; RNA; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; ANION EXCHANGE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PH; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANION TRANSPORT PROTEINS; ANNEXIN A5; ANTIGENS, CD11B; ANTIGENS, CD11C; ANTIPORTERS; APOPTOSIS; ARSENICALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; FLOW CYTOMETRY; HUMANS; HYDROGEN-ION CONCENTRATION; LEUKEMIA, PROMYELOCYTIC, ACUTE; OXIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33746493306     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06224.x     Document Type: Article

References (39)

1. Alper, S.L. (2006) Molecular physiology of SLC4 anion exchangers. Experimental Physiology, 91, 153-161.
2. Alper, S.L., Chernova, M.N. & Stewart, A.K. (2002) How pH regulates a pH regulator: a regulatory hot spot in the N-terminal cytoplasmic domain of the AE2 anion exchanger. Cell Biochemistry and Biophysics, 36, 123-136.
3. Bao-Lei, T., Zhu-Zhong, M., Yi, S., Jun-Jie, Q., Yan, D., Hua, L., Bin, L., Guo-Wei, Z. & Zhi-Xian, S. (2006) Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7. Journal of Cellular Biochemistry, 97, 561-571.
4. Cavigelli, M., Li, W.W., Lin, A., Su, B., Yoshioka, K. & Karin, M. (1996) The tumor promoter arsenite stimulates AP-I activity by inhibiting a JNK phosphatase. EMBO Journal, 15, 6269-6279.
5. Chen, G.Q., Shi, X.G., Tang, W., Xiong, S.M., Zhu, J., Cai, X., Han, Z.G., Ni, J.H., Shi, G.Y., Jia, P.M., Liu, M.M., He, K.L., Niu, C., Ma, J., Zhang, P., Zhang, T.D., Paul, P., Naoe, T., Kitamura, K., Miller, W., Waxman, S., Wang, Z.Y., de The, H., Chen, S.J. & Chen, Z. (1997) Use of arsenic trioxide (Arsenic trioxide) in the treatment of acute promyelocytic leukemia (APL): I. Arsenic trioxide exerts dosedependent dual effects on APL cells. Blood, 89, 3345-3353.
6. Ching, R.W., Dellaire, G., Eskiw, C.H. & Bazett-Jones, D.P. (2005) PML bodies: a meeting place for genomic loci? Journal of Cell Science, 118, 847-854.
7. Chou, W.C. & Dang, C.V. (2005) Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies. Current Opinion in Hematology, 12, 1-6.
8. Davison, K., Mann, K.K., Waxman, S. & Miller, W.H., Jr (2004) JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells. Blood, 103, 3496-3502.
9. Delnomdedieu, M., Basti, M.M., Styblo, M., Otvos, J.D. & Thomas, D.J. (1994) Complexation of arsenic species in rabbit erythrocytes. Chemical Research in Toxicology, 7, 621-627.
10. Fu, G.H., Wang, Y., Xi, Y.H., Shen, W.W., Pan, X.Y., Shen, W.Z., Jiang, X.S. & Chen, G.Q. (2005a) Direct interaction and cooperative role of tumor suppressor p16 with band 3 (AE1). FEBS Letters, 579, 2105-2110.
11. Fu, G.H., Wang, Y., Xi, Y.H., Guo, Z.W., Liu, X.B., Bai, S.Z., Yang, B.F. & Chen, G.Q. (2005b) Arsenic trioxide enhances the anion transport activity of band 3 and the action is related with the C-terminal 16 residues of the protein. Journal of Drug Targeting, 13, 235-243.
12. Gallagher, R.E., Yeap, B.Y., Bi, W., Livak, K.J., Beaubier, N., Rao, S., Bloomfield, C.D., Appelbaum, F.R., Tallman, M.S., Slack, J.L. & Willman, C.L. (2003) Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129. Blood, 101, 2521-2528.
13. Glasow, A., Prodromou, N., Xu, K., von Lindern, M. & Zelent, A. (2005) Retinoids and myelomonocytic growth factors cooperatively activate RARA and induce human myeloid leukemia cell differentiation via MAP kinase pathways. Blood, 105, 341-349.
14. Hei, T.K. & Filipic, M. (2004) Role of oxidative damage in the genotoxicity of arsenic. Free Radical Biology Medicine, 37, 574-581.
15. Isfort, R.J., Cody, D.E., Asquith, T.N., Ridder, G.M., Stuard, S.B. & LeBoeuf, R.A. (1993) Induction of protein phosphorylation, protein synthesis, immediate-early-gene expression and cellular proliferation by intracellular pH modulation. Implications for the role of hydrogen ions in signal transduction. European Journal of Biochemistry, 213, 349-357.
16. Ivanov, V.N. & Hei, T.K. (2004) Arsenite sensitizes human melanomas to apoptosis via tumor necrosis factor α-mediated pathway. Journal of Biological Chemistry, 279, 22747-22758.
17. Kopito, R.R., Lee, B.S., Simmons, D.M., Lindsey, A.E., Morgans, C.W. & Schneider, K. (1989) Regulation of intracellular pH by a neuronal homolog of the erythrocyte anion exchanger. Cell, 59, 927-937.
18. - exchanger. Journal of Biological Chemistry, 265, 462-471.
19. Lanotte, M., Martin-Thouvenin, V., Najman, S., Balerini, P., Valensi, F. & Berger, R. (1991) NB4, a maturation inducible cell line with t (15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood, 77, 1080-1086.
20. Li, Y.P., Andersen, J., Zelent, A., Rao, S., Paietta, E., Tallman, M.S., Wiernik, P.H. & Gallagher, R.E. (1997) RAR alpha1/RAR alpha2-PML mRNA expression in acute promyelocytic leukemia cells: a molecular and laboratory-clinical correlative study. Blood, 90, 306-312.
21. Madshus, I.H. (1988) Regulation of intracellular pH in eukaryotic cells. Biochemical Journal, 250, 1-8.
22. Mahieux, R., Pise-Masison, C., Gessain, A., Brady, J.N., Olivier, R., Perret, E., Misteli, T. & Nicot, C. (2001) Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage. Blood 98, 3762-3769.
23. Medina, J.F., Recalde, S., Prieto, J., Lecanda, J., Saez, E., Funk, C.D., Vecino, P., van Roon, M.A., Ottenhoff, R., Bosma, P.J., Bakker, C.T. & Elferink, R.P. (2003) Anion exchanger 2 is essential for spermiogenesis in mice. Proceedings of the National Academy of Sciences, 100, 15847-15852.
24. Miller, W., Schipper, H.M., Lee, J.S., Singer, J. & Waxman, S. (2002) Mechanisms of action of arsenic trioxide. Cancer Research, 62, 3893-3903.
25. Okubo, K., Kang, D., Hamasaki, N. & Jennings, M.L. (1994) Red blood cell band 3. Lysine 539 and lysine 851 react with the same H2DIDS (4,4′-diisothiocyanodihydrostilbene-2, 2′-disulfonic acid) molecule. Journal of Biological Chemistry, 269, 1918-1926.
26. Porter, A.C., Fanger, G.R. & Vaillancourt, R.R. (1999) Signal transduction pathways regulated by arsenate and arsenite. Oncogene, 18, 7794-7802.
27. Puceat, M., Roche, S. & Vassort, G. (1998) Src family kinase regulates intracellular pH in cardiomyocytes. Journal of Cell Biology, 7, 637-646.
28. + exchanger, NHE1: structure, regulation, and cellular actions. Annual Review of Pharmacology and Toxicology, 42, 527-552.
29. Reynolds, T.Y., Rockwell, S. & Glazer, P.M. (1996) Genetic instability induced by the tumor microenvironment. Cancer Research, 56, 5754-5757.
30. Shen, M.R., Wilkins, R.J., Chou, C.Y. & Ellory, J.C. (2002) Anion exchanger isoform 2 operates in parallel with Na(+)/H(+) exchanger isoform 1 during regulatory volume decrease of human cervical cancer cells. FEBS Letters, 512, 52-58.
31. Soignet, S.L., Maslak, P., Wang, Z.G., Jhanwar, S., Calleja, E., Dardashti, L.J., Corso, D., DeBlasio, A., Gabrilove, J., Scheinberg, D.A., Pandolfi, P.P. & Warrell, R.P., Jr (1998) Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. New England Journal of Medicine, 339, 1341-1348.
32. Stewart, A.K., Chernova, M.N., Kunes, Y.Z. & Alper, S.L. (2001) Regulation of AE2 anion exchanger by intracellular pH: critical regions of the NH(2)-terminal cytoplasmic domain. American Journal of Physiology - Cell Physiology, 281, C1344-C1354.
33. Tanner, M.J. (1997) The structure and function of band 3 (AE1): recent developments (review). Molecular Membrane Biology, 14, 155-165.
34. Wang, T.S., Shu, Y.F., Liu, Y.C., Jan, K.Y. & Huang, H. (1997) Glutathione peroxidase and catalase modulate the genotoxicity of arsenite. Toxicology, 121, 229-237.
35. Zheng, Y., Shi, Y., Tian, C., Jiang, C., Jin, H., Chen, J., Almasan, A., Tang, H. & Chen, Q. (2004) Essential role of the voltage-dependent anion channel (VDAC) in mitochondrial permeability transition pore opening and cytochrome c release induced by arsenic trioxide. Oncogene, 23, 1239-1247.
36. Zhou, L., Jing, Y., Styblo, M., Chen, Z. & Waxman, S. (2005) Glutathione S-transferase {pi} inhibits arsenic trioxide-induced apoptosis in lymphoma cells: involvement of hydrogen peroxide catabolism. Blood, 105, 1198-1203.
37. Zhu, J., Koken, M.H., Quignon, F., Chelbi-Alix, M.K., Degos, L., Wang, Z.Y., Chen, Z. & de The, H. (1997) Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proceedings of the National Academy of Sciences, 94, 3978-3983.
38. Zhu, J., Okumura, H., Ohtake, S., Nakamura, S. & Nakao, S. (2003a) Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system. Oncology Reports, 3, 705-709.
39. Zhu, Q., Lee, D.W.K., Casey, J.R. (2003b). Novel topology in C-terminal region of the human plasma membrane anion exchanger, AE1. Journal of Biological Chemistry, 278, 3312-3320.